Xortx Therapeutics Inc (XRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,194 | 1,064 | 1,895 | 2,474 | 2,301 |
| Receivables | 22 | 11 | 17 | 18 | 13 |
| Other current assets | 111 | 93 | 0 | 0 | 0 |
| TOTAL | $1,358 | $1,265 | $2,103 | $2,677 | $2,410 |
| Non-Current Assets | |||||
| PPE Net | 60 | 83 | 15 | 35 | 54 |
| Intangibles | 194 | 195 | 180 | 183 | 186 |
| Other Non-Current Assets | 1,200 | 1,200 | 1,200 | 1,200 | 1,200 |
| TOTAL | $1,454 | $1,478 | $1,395 | $1,418 | $1,440 |
| Total Assets | $2,811 | $2,742 | $3,499 | $4,095 | $3,850 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 677 | 454 | 416 | 147 | 326 |
| Other current liabilities | 101 | 177 | 326 | 572 | 1,329 |
| TOTAL | $837 | $712 | $757 | $758 | $1,717 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $837 | $712 | $757 | $758 | $1,717 |
| Shareholders' Equity | |||||
| Common Shares | 19,489 | 18,913 | 18,913 | 18,494 | 17,871 |
| Retained earnings | -23,234 | -22,585 | -21,867 | -21,168 | -21,291 |
| Other shareholders' equity | 5,719 | 5,703 | 5,696 | 6,011 | 5,553 |
| TOTAL | $1,974 | $2,031 | $2,741 | $3,337 | $2,134 |
| Total Liabilities And Equity | $2,811 | $2,742 | $3,499 | $4,095 | $3,850 |